Concerned About Lung Cancer?

Early Detection Saves Lives

US Deaths by Cancer Type
Lung cancer is, by far, the leading cause of cancer deaths in the US. It kills more people than breast cancer, colon cancer and prostate cancers COMBINED. Most cases of lung cancer are diagnosed in the later stages of disease development, when the cancer has spread to other organs in the body. Survival at this point has relatively low odds as treatment options are limited due to the metastasis of the disease. With early detection tests, lung cancer can be diagnosed before it has spread, when survival rates are much higher since the tumor can be surgically removed.

About PAULA’s Test

20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed laboratory, Genesys Biolabs (CLIA Lic# 21D2037411). PAULA’s Test is meant for use in patients at high risk of lung cancer due to long term smoking. PAULA’s Test can help detect lung cancer in patients without symptoms, even at the earliest stages. While lung screening using Low Dose CT scans is available today at many hospitals, many patients do not meet the eligibility criteria to receive screening tests. For patients who are at risk for lung cancer but either do not meet eligibility or who choose not to undergo annual CT scans, PAULA’s Test may be an option for a test for early detection.

Physicians and Patients interested in learning more about PAULA’s Test should visit our laboratory site for complete information.